Journals in Life sciences
Journals in Life sciences
Progress in Biophysics & Molecular Biology
Aims and Scope: Progress in Biophysics &Molecular Biology is an international review journal and covers the ground between the physical and biological sciences since its launch in 1950. It indicates to the physicist the great variety of unsolved problems awaiting attention in biology and medicine. The biologist and biochemist will find that this journal presents new and stimulating ideas and novel approaches to studying and influencing structural and functional properties of the living organism. This journal will be of particular interest to biophysicists, biologists, biochemists, cell physiologists, systems biologists, and molecular biologists. The purpose of the journal is to present invited, informative and critical reviews of recent advances in different aspects of biophysics and molecular biology. The Editors welcome suggestions of topics and potential authors. As the scope of Progress in Biophysics &Molecular Biology is wide and of interest to scientists in many disciplines, authors should treat their subject matter in a manner that is authoritative yet also easily comprehensible to those who are not experts in the field. Whilst the aim of the journal is primarily to publish substantial articles reviewing progress over an extensive field, review articles covering recent advances on more limited topics are also welcome. In addition, the journal publishes many Thematic Special Issues dedicated to specific areas of investigation - often linked to high-level international conferences - that contain both substantive reviews and original research papers.- ISSN: 0079-6107
Clinical Neurology and Neurosurgery
Clinical Neurology and Neurosurgery is devoted to publishing papers and reports on the clinical aspects of neurology and neurosurgery. It is an international forum for papers of high scientific standard that are of interest to Neurologists and Neurosurgeons world-wide.Rehabilit... topics, as well as genetics (Mendelian randomizations) are no longer accepted.Professor Florian Roser, Cleveland Clinic Abu Dhabi Neurological Institute, P.O. Box 11 24 12, Abu Dhabi, United Arab Emirates is the Editor-in-Chief. The journal has a broad international perspective.Types of Papers: - Original Article- Review Article- Editorial- Letter to the Editor- Correspondence- Book Review- Discussion- Opinion Paper- ISSN: 0303-8467
Matrix Biology
Affiliated with the American Society for Matrix Biology and the International Society for Matrix BiologyMatrix Biology is the leading journal devoted to publishing the latest research on molecular components of the extracellular matrix and the biological impact of cellular interactions with extracellular matrices. The journal welcome articles in any area of extracellular matrix research that provide new mechanistic and functional insights, have significant potential impact for the field, or which challenge longstanding biological paradigms. Matrix Biology publishes original studies in, but not limited to, cell and molecular biology, developmental biology, genetics, structural biology, chronobiology, infection and immunity, immunology, virology, signaling, disease mechanisms, and therapeutics related to the extracellular matrix and its interactions with cells. Papers considered for peer review document substantial advances for the field of extracellular matrix and/or cell-matrix interactions. In addition to original research articles, Matrix Biology welcomes highly timely, impactful reviews. Please view our Guide for Authors for more information. Matrix Biology was established in 1980 as Collagen and Related Research, an international scientific journal for publication of research on the extracellular matrix. The journal became Matrix (1989-1993) and then Matrix Biology in 1994 to reflect the expansion of knowledge and interest in the diversity of extracellular matrix-associated molecules and their importance in development, health, and disease.Matrix Biology, has a companion title, Matrix Biology Plus. Matrix Biology Plus is an online-only, open access journal that welcomes papers reporting novel advances in the field of matrix biology and related research tools and resources without a strict requirement for novel biological mechanisms.- ISSN: 0945-053X
Frontiers in Neuroendocrinology
Frontiers in Neuroendocrinology (FIN) is comprised of comprehensive review articles, systematic reviews, opinion pieces, and meta-analyses. Most of the reviews are invited but we welcome unsolicited reviews and meta-analyses, and proposals for thematic special issues provided they meet the quality threshold of the journal. We also encourage authors to submit proposals for commentaries which succinctly raise new ideas or provide additional analysis to further explore ramifications of an article published in the journal.Research areas of interest include:Endocrine interactions that influence neuropsychiatric and neurodegenerative diseaseSex differences in clinical populations and in pre-clinical modelsStress and stress systems interactions with health and diseaseNeuroendocrin... influences on health across the lifespan from development, puberty, adulthood and agingMicrobiota/neur... interactions with health and diseaseNeuroendocrin... -immune interactions: links to behavior and diseaseIntegrative cellular, molecular and behavioral aspects of hormonally active neuropeptidesCompara... and clinical neuroendocrinologyNe... control of energy balance, glucose homeostasis, and metabolism- ISSN: 0091-3022
Microvascular Research
Microvascular Research is dedicated to the dissemination of fundamental information related to the microvascular field. Full-length articles presenting the results of original research and brief communications are featured.Research Areas include: • Angiogenesis • Biochemistry • Bioengineering • Biomathematics • Biophysics • Cancer • Circulatory homeostasis • Comparative physiology • Drug delivery • Neuropharmacology • Microvascular pathology • Rheology • Tissue EngineeringUS National Institutes of Health (NIH) voluntary posting ("Public Access") policyMicrovascular Research and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors- ISSN: 0026-2862
Neuropeptides
The aim of Neuropeptides is the rapid publication of original research and review articles, dealing with the structure, distribution, actions and functions of peptides in the central and peripheral nervous systems. The explosion of research activity in this field has led to the identification of numerous naturally occurring endogenous peptides which act as neurotransmitters, neuromodulators, or trophic factors, to mediate nervous system functions. Increasing numbers of non-peptide ligands of neuropeptide receptors have been developed, which act as agonists or antagonists in peptidergic systems.The journal provides a unique opportunity of integrating the many disciplines involved in all neuropeptide research. The journal publishes articles on all aspects of the neuropeptide field, with particular emphasis on gene regulation of peptide expression, peptide receptor subtypes, transgenic and knockout mice with mutations in genes for neuropeptides and peptide receptors, neuroanatomy, physiology, behaviour, neurotrophic factors, preclinical drug evaluation, clinical studies, and clinical trials.Original papers predominate. Manuscripts may be of any length, but must be complete studies; preliminary communications are not accepted. Review articles and hypothesis papers are welcomed, and will be evaluated in the same way as experimental papers. Authors intending to submit a review are advised to communicate their intentions to the Editor, to avoid possible duplication.- ISSN: 0143-4179
Journal of Aging Studies
The Journal of Aging Studies features scholarly articles offering theoretically engaged interpretations that challenge existing theory and empirical work. Articles need not deal with the field of aging as a whole, but with any defensibly relevant topic pertinent to the aging experience and related to the broad concerns and subject matter of the social and behavioral sciences and the humanities. The journal emphasizes innovation and critique - new directions in general - regardless of theoretical or methodological orientation or academic discipline. Potential contributors are strongly advised to consult recent issues of the Journal for examples of articles that fit this mission.Further information for authors. The COVID-19 pandemic has resulted in both higher rates of submissions to JAS and much lower reviewer acceptance rates. In light of this, we ask two things of the community. First, patience with the longer lag time from submission to notification and reviewer comments. Second, if you submit a manuscript for consideration, then we hope you will do your part if asked to review for us in the future. Thank you for your understanding and help in ensuring the peer-review process continues as efficiently and robustly as possible in these trying times.- ISSN: 0890-4065
Current Opinion in Toxicology
Affiliated with the International Union of ToxicologyCurrent Opinion in Toxicology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise, and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Toxicology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Current Opinion in Toxicology serves as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Current Opinion in Toxicology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Toxicology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.Division of the subject into sections: For this purpose, the scope of Current Opinion in Toxicology is divided into seven selected, high impact themed sections:Mechanistic ToxicologyMetabolic ToxicologyRisk assessment in ToxicologyGenomic ToxicologySystems ToxicologyTranslatio... ToxicologyGeneral Toxicology (direct submission)Expertise... Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant. Comprehensiveness: There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry. Impact: In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores. Discoverability: Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast, global audience.Selection of topics to be reviewed Editors, who are major authorities in the field, are approved by the Editors-in-Chief of the journal. They divide their sections into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Editors commission reviews from authors on each topic that they have selected and arrange for the peer review process. The papers are reviewed by 2 independent reviewers.Submission... Opinion in Toxicology allows two ways to submit to the journal:Invitation – in accordance with the established procedure for all Current Opinion titles, andDirect submission - authors are invited to submit directly via the submission system Editorial Manager. All submissions are subject to the standard, rigorous peer review by the journal Editors, as well as completeness and relevance check at submission to ensure high quality and research integrity requirements are met. The direct submission papers, if accepted, will be published in the General Toxicology section of the journal.Short ReviewsAuthors are asked to submit short review opinion type articles, in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the 5 years. Original research papers and systematic reviews will not be considered. These can be submitted to the companion journal Current Research in Toxicology.Editorial Overview For invitation only sections, Section Editors write a short overview at the beginning of the section, to introduce the reviews and to draw the reader's attention to any particularly interesting developments.Ethics in Publishing: General Statement The Editors and the Publisher of this journal believe that there are fundamental principles underlying scholarly and professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper, are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the journal is the safest course. All submissions to the journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The journal may use such information as a basis for editorial decisions and may publish such disclosures, if they are believed to be important to readers in judging the manuscript. A decision may be made by the journal not to publish on the basis of the declared conflict.For more information, please refer to: https://www.elsevier...- ISSN: 2468-2020
Journal of Human Evolution
The Journal of Human Evolution concentrates on publishing the highest quality papers covering all aspects of human evolution. The central focus is aimed jointly at paleoanthropological work, covering human and primate fossils, and at comparative studies of living species, including both morphological and molecular evidence. These include descriptions of new discoveries, interpretative analyses of new and previously described material, and assessments of the phylogeny and paleobiology of primate species. Submissions should address issues and questions of broad interest in paleoanthropology.In addition to original research papers, space is allocated for the rapid publication of short communications on new discoveries, such as exciting new fossils, as well as to lead book reviews and obituariesResearch Areas Include:Paleoanthrop... work, covering human and primate fossilsComparative studies of living species, including both morphological and molecular evidencePrimate systematics and phylogeny, behaviorFunctional studies, particularly relating to diet and locomotionBody size and allometric studiesStudies in Paleolithic archaeologyTaphonomi... stratigraphical, and geochronological studies supporting fossil evidence for primate and human evolutionGenetic and paleoproteomic approaches to human evolutionPaleoecolog... and paleogeographical models for primate and human evolutionPlease see the Guide for Authors for further information.- ISSN: 0047-2484
Pulmonary Pharmacology & Therapeutics
Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.Research Areas Include:• All major diseases of the lung • Physiology • Pathology • Drug delivery • Metabolism • Pulmonary ToxicologyBefore submitting, please note the "Rules of 5" defining immediate rejection criteria of PPT:1. Out of scope: The paper should report on the use of pharmacological or toxicological studies (positive or negative) that are directly related to Pulmonary Pharmacology & Therapeutics.Immedia... rejection criteria are: a) Testing of extracts or plant parts that are not characterized b) Case Reports or n=1 studies2. Too preliminary: A paper must be based on a thorough and extensive study, using proper controlsImmediate rejection criteria are: a) In vitro studies with a single dose, or very high concentration b) Single dose studies with very few animals, no dose-response studies c) No proper controls. d) Repetition or confirmation of an earlier work3. Unethical: The study must have been carried under appropriate ethical approval for the study (either animal or human).4. Inappropriate experiments or lacking essential detailImmediate rejection criteria are: a) Wrong species or lacking details on the exact number of animals/subjects used b) No details of structure if a new drug is used for the first time5. Lack of novelty: The study must represent a novel approach to the field.Immediate rejection criteria are: a) Repetition of well known data b) No advance of knowledge in the fieldNote that only manuscripts written in good English will be considered by the Editors (British usage is preferred).- ISSN: 1094-5539
